In Treatment of Schizophrenia Schizophrenia is a mental disorder in which a person’s thinking ability, feelings and behavior become abnormal. Trilu 1 Tablet helps restore the chemical imbalances in the brain that are responsible for such changes. It improves thoughts, behavior and enhances the quality of life. It needs to be taken regularly to work effectively. Do not stop taking it unless your doctor advises you to as it can worsen your condition. In Short term anxiety Trilu 1 Tablet reduces the symptoms of excessive anxiety and worry that are triggered only at the time of stressful conditions that last for a shorter duration. These could be job interviews, exams, stage performances, etc. It can effectively manage feelings of restlessness, tiredness, difficulty concentrating and feeling irritable. Trilu 1 Tablet will therefore help you go about your daily activities more easily and be more productive. Keep taking this medicine even if you feel well. Stopping suddenly can cause serious problems.
Trilu 1 Tablet may cause excessive drowsiness with alcohol.
Trilu 1 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Trilu 1 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Trilu 1 Tablet may cause side effects which could affect your ability to drive. Trilu 1 Tablet make u feel dizzy, drowsy or can cause blurred vision. This may affect your driving ability.
There is limited information available on the use of Trilu 1 Tablet in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Trilu 1 Tablet in patients with liver disease. Please consult your doctor. However, the use of Trilu 1 Tablet is not considered safe in patients with liver disease as per the available data.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: D D Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Glaxo SmithKline Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ryon Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Glaxo SmithKline Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Exelife Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Saga Laboratories || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ishjas Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)